Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Qvents Qvents
  • Home 
    • About Us 
    • Contact Us 
    • Expert Panel 
    • Tags 
  • Qvents 
    • Warning Letters 
    • 483s 
    • Recalls 
    • Import Alerts 
    • Quality Insights 
    • Tags 
  • Forums 
  • Learning Resources 
    • Upcoming Trainings 
    • Training Archives 
  • Guidelines 
  • Pharma Jobs 
    • Job Openings 
    • Post a Job
      • Jobs posted by me 
  • Users & Profiles 
  • News 
  • Login/Register
    • Individual
    • Company
Qvents Qvents
Qvents
  • Home 
    • About Us 
    • Contact Us 
    • Expert Panel 
    • Tags 
  • Qvents 
    • Warning Letters 
    • 483s 
    • Recalls 
    • Import Alerts 
    • Quality Insights 
    • Tags 
  • Forums 
  • Learning Resources 
    • Upcoming Trainings 
    • Training Archives 
  • Guidelines 
  • Pharma Jobs 
    • Job Openings 
    • Post a Job
      • Jobs posted by me 
  • Users & Profiles 
  • News 
  • Login/Register
shape
shape
shape
shape

Sun Pharma initiates a Class II recall of 12960 vials of Amphotericin B Liposome for Injection, manufactured by Sun Pharma Halol, India for sub potency issues Read More..

Qvents

0 minutes read
  1. Home
  2. News
  3. Sun Pharma initiates a Class II recall of 12960 vials of Amphotericin B Liposome for Injection, manufactured by Sun Pharma Halol, India for sub potency issues <a href="https://www.accessdata.fda.gov/scripts/ires/?Event=92425" target="_blank" rel="noopener">Read More..</a>
Updated on October 31, 2024
shape
shape
shape
shape
  1. Home
  2. News
  3. Sun Pharma initiates a Class II recall of 12960 vials of Amphotericin B Liposome for Injection, manufactured by Sun Pharma Halol, India for sub potency issues <a href="https://www.accessdata.fda.gov/scripts/ires/?Event=92425" target="_blank" rel="noopener">Read More..</a>
Updated on October 31, 2024

Tags : Recall
Share:

Leave a Comment Cancel reply

You must be logged in to post a comment.

  • Facebook
  • LinkedIn
  • Twitter

Search Posts

Latest Posts

Shiva Analytical Warning Letter: Data Integrity, Deficient OOS Handling Cited
August 14, 2025
Qvents Apps and Tools For QMS and GMP Processes
August 8, 2025
Glenmark Warning Letter Cites 21 CFR 211.192 Violations at Multiple Sites
August 7, 2025
Natco Pharma USFDA 483 Flags Deficiencies in Aseptic Areas, Validation
August 2, 2025
Loss of Potency: Accord / Intas Recall Hypothyroidism / Thyroxine Drug
July 25, 2025
footer shape 1
footer shape 2
 Quick Links 
  • Forums
  • Warning Letters
  • 483s
  • Recalls
  • Import Alerts
  • Quality Insights
 
  • News
  • Guidelines
  • Pharma Jobs
  • Job Openings
  • Post a Job
 
  • Users & Profiles
  • Trainings and Webinar
  • About Us
  • Contact Us
  • Facebook
  • LinkedIn
  • Twitter

© 2023 All Rights Reserved by Qvents

  • Terms and Conditions
  • Privacy Policy